EUVIMEDEUVIMED entdecken
Crossref

L26/P-667 Resolving Unexpected Prenatal Findings After PGT A Using DNA Fingerprinting Analysis

T. Gordon, N. Paolino, K. Mcwilliams

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.997 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von T. Gordon und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Can DNA fingerprinting analysis provide clinically relevant insight into the etiologies of discordant PGT-A and prenatal genetic testing results? Summary answer DNA fingerprinting analyses identified confirmed embryonic mosaicism and maternal cell contamination of embryo biopsies as root causes of discordant PGT-A and prenatal genetic testing results. What is known already Preimplantation genetic testing for aneuploidy (PGT-A) screens IVF embryos for abnormal chromosome numbers that can cause implantation failure or early pregnancy loss. It also identifies euploid embryos, which are more likely to result in sustained pregnancy and live birth. Using next generation sequencing (NGS), PGT-A can also detect intermediate copy number (mosaicism) within trophectoderm biopsies. Prenatal testing after PGT-A is always recommended. Infrequently, discordant results arise between PGT-A tested biopsies and prenatal results of the fetus. We hypothesized that comparing DNA from PGT-A materials, prenatal samples, and parental genomic DNA could clarify the causes of these discrepancies. Study design, size, duration This retrospective study examined 64 cases with discordant PGT-A and prenatal testing results over a 5-year period. DNA comparative analyses were performed using residual PGT-A materials, prenatal testing samples, and genomic DNA from the gamete contributors. PGT-A testing was ordered by clinicians, and individual consent for the additional DNA comparison studies was obtained from each family. All personally identifying information was removed. Participants/materials, setting, methods PGT-A was performed by a commercial laboratory using a high resolution NGS platform incorporating dual CNV and SNP analysis. Genomic DNA for gamete contributors was collected via buccal swab. Residual embryo DNA was stored in the original biopsy tube labeled and submitted by the IVF laboratory and original PGT-A results confirmed by reanalysis of the sample(s) in question. DNA fingerprinting was conducted via a short-tandem repeat (STR)-based platform (Aneufast™ QF-PCR Kit, Genomed). Main results and the role of chance DNA fingerprinting was performed in 64 cases with discordant PGT-A and prenatal testing results. Interpretable STR profiles were obtained from residual trophectoderm biopsy DNA in 61/64 cases (95.3%). Fetal DNA was unavailable in 8 cases; these underwent limited comparison of embryo and gamete contributor DNA, confirming intended parentage in all. Parentage was also confirmed in 53 cases where availability of fetal DNA made full comparative analysis possible. Of these, in 21 cases with autosomal discordance, embryo biopsy and fetal DNA profiles were concordant, indicating transfer of the indexed embryo and suggesting embryonic mosaicism as the source of discordant results. Sixteen cases showed a PGT-A result of euploid female but a male fetus on prenatal testing; STR profiling demonstrated a match between the biopsy sample and maternal DNA, consistent with substantial maternal cell contamination. In 8 cases, fetal DNA matched a different embryo within the tested cohort, implicating biopsy mislabeling or transfer of an unintended embryo. In 4 cases, fetal DNA matched no embryo in the cohort, consistent with spontaneous conception or transfer of an untested embryo. No errors attributable to the PGT-A laboratory were identified. Limitations, reasons for caution This study represents a distinct cohort of cases with discrepant PGT-A and prenatal genetic testing results that were investigated by a single PGT-A laboratory. Study of additional cases and similar investigation by additional PGT laboratories is recommended to confirm broader applicability of these findings. Wider implications of the findings PGT-A via NGS with dual CNV and SNP approach is highly accurate to determine the chromosomal status of trophectoderm biopsies. However, discordant PGT-A and prenatal results will occur. STR profile comparison between embryo biopsies, prenatal samples and parental DNA can elucidate biologic and potentially preventable causes for testing discordances. Trial registration number No

Zitieren

APA

Gordon, T., Paolino, N., & Mcwilliams, K. (2026). L26/P-667 Resolving Unexpected Prenatal Findings After PGT A Using DNA Fingerprinting Analysis. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.997

Vancouver

Gordon T, Paolino N, Mcwilliams K. L26/P-667 Resolving Unexpected Prenatal Findings After PGT A Using DNA Fingerprinting Analysis. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.997

BibTeX
@article{Gordon2026,
  author = {Gordon, T. and Paolino, N. and Mcwilliams, K.},
  title = {L26/P-667 Resolving Unexpected Prenatal Findings After PGT A Using DNA Fingerprinting Analysis},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.997}
}
Kostenlos starten →